Johannes Schetelig Selected Research

Disseminated Intravascular Coagulation

1/2021

Case Report: ANXA2 Associated Life-Threatening Coagulopathy With Hyperfibrinolysis in a Patient With Non-APL Acute Myeloid Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johannes Schetelig Research Topics

Disease

47	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 09/2008
23	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 03/2002
20	Neoplasms (Cancer) 03/2024 - 03/2010
20	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024 - 05/2007
15	Leukemia 12/2023 - 11/2005
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 01/2009
6	Infections 01/2020 - 11/2005
5	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 11/2005
4	Pathologic Complete Response 04/2024 - 11/2019
4	Lymphoma (Lymphomas) 12/2023 - 10/2002
3	Tumor Lysis Syndrome 01/2024 - 03/2014
3	Residual Neoplasm 10/2022 - 11/2009
3	Disease Progression 01/2020 - 02/2015
3	Multiple Myeloma 01/2020 - 11/2016
2	Bronchiolitis Obliterans Syndrome 01/2022 - 03/2002
2	Cytopenia 01/2022 - 09/2008
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021 - 12/2020
2	COVID-19 04/2021 - 01/2021
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2019 - 01/2019
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2019 - 04/2004
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019 - 01/2018
2	Iron Overload 05/2018 - 12/2012
2	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 01/2009
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2009 - 09/2008
1	Hematologic Diseases (Blood Diseases) 03/2024
1	Back Pain (Backache) 12/2022
1	Body Weight (Weight, Body) 01/2021
1	Disseminated Intravascular Coagulation 01/2021
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 01/2021
1	Clostridium Infections 01/2020

Drug/Important Bio-Agent (IBA)

5	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024 - 07/2011
5	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 03/2002
5	fludarabineIBA 01/2020 - 10/2002
4	venetoclaxIBA 01/2024 - 06/2016
4	idelalisibIBA 02/2022 - 12/2020
4	Alemtuzumab (Campath)FDA Link 10/2015 - 04/2004
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2024 - 12/2019
3	Calcineurin InhibitorsIBA 01/2024 - 01/2009
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2023 - 03/2002
3	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 09/2012
3	Peptides (Polypeptides)IBA 01/2021 - 06/2011
3	purineIBA 11/2019 - 12/2014
3	NucleophosminIBA 01/2018 - 03/2016
2	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2024 - 06/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 10/2002
2	KIR ReceptorsIBA 12/2023 - 11/2023
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2023 - 03/2002
2	AntigensIBA 11/2023 - 11/2016
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 01/2009
2	EpitopesIBA 01/2021 - 02/2018
2	Minor Histocompatibility AntigensIBA 01/2021 - 04/2012
2	ibrutinibIBA 01/2020 - 01/2019
2	Busulfan (Busulfex)FDA Link 01/2020 - 03/2010
2	Proteins (Proteins, Gene)FDA Link 02/2018 - 11/2016
2	Clofarabine (Clolar)FDA Link 12/2017 - 06/2016
2	rasburicase (Elitek)FDA Link 01/2017 - 03/2014
2	RheniumIBA 10/2015 - 03/2010
2	Cidofovir (Vistide)FDA Link 06/2007 - 01/2007
2	Foscarnet FDA LinkGeneric 06/2007 - 04/2004
1	Cetrimonium (CTAB)IBA 03/2024
1	Immunoglobulins (Immunoglobulin)IBA 12/2023
1	LigandsIBA 11/2023
1	tyramine-deoxysorbitolIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	CohesinsIBA 01/2023
1	ChromatinIBA 01/2023
1	midostaurinIBA 01/2023
1	AntibodiesIBA 10/2022
1	isocitric acid (isocitrate)IBA 01/2022
1	trans-crotonin (CTN)IBA 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021
1	CPX-351IBA 10/2021
1	CC ChemokinesIBA 04/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	plerixafor FDA Link 01/2021
1	Decitabine FDA Link 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	treosulfanIBA 01/2020
1	Core Binding Factors (Core-Binding Factor)IBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2020

Therapy/Procedure

28	Cell Transplantation 03/2024 - 09/2008
28	Stem Cell Transplantation 01/2024 - 11/2003
22	Hematopoietic Stem Cell Transplantation 03/2024 - 11/2005
20	Therapeutics 03/2024 - 04/2004
15	Transplantation 03/2024 - 09/2008
8	Drug Therapy (Chemotherapy) 04/2024 - 11/2003
4	Homologous Transplantation 12/2023 - 03/2002
4	Salvage Therapy 01/2022 - 09/2008
4	Radioimmunotherapy 01/2020 - 03/2010
1	Remission Induction 04/2024
1	Consolidation Chemotherapy 01/2023
1	Physical Therapy Modalities (Physical Therapy Technique) 12/2022
1	Blood Component Removal (Apheresis) 01/2021
1	Donor Selection 01/2020